The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease.
Clinical trial NCT07344519 · COMPLETED
Trial details
- NCT number
- NCT07344519
- Sponsor
- ExoRNA Bioscience
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2025-06-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.